Ocular Therapeutix (OCUL) Asset Utilization Ratio (2014 - 2026)
Ocular Therapeutix's quarterly Asset Utilization Ratio came in at 0.07 in Q1 2026, down 51.08% year-on-year from 0.14 in Q1 2025, and down 20.75% quarter-over-quarter from 0.09 in Q4 2025.
Ocular Therapeutix has reported Asset Utilization Ratio for 13 years, with the latest figure at 0.07 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio fell 51.08% year-over-year to 0.07; the trailing twelve-month figure through Mar 2026 stood at 0.07 (down 51.08% YoY), and the FY2025 full-year result was 0.08, down 54.28% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.07, down from 0.09 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.43 in Q2 2023, with the low at 0.07 in Q1 2026.
- Average Asset Utilization Ratio over 5 years is 0.22, with a median of 0.15 recorded in 2024.
- Year-over-year, Asset Utilization Ratio soared 186.87% in 2022 and plunged 73.39% in 2024.
- Tracing OCUL's Asset Utilization Ratio over 5 years: stood at 0.33 in 2022, then declined by 15.69% to 0.28 in 2023, then sank by 52.35% to 0.13 in 2024, then tumbled by 36.57% to 0.09 in 2025, then dropped by 20.75% to 0.07 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.07 (Q1 2026), 0.09 (Q4 2025), and 0.13 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.85 |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | 0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.07 |
| Dec 31, 2025 | 0.09 |
| Sep 30, 2025 | 0.13 |
| Jun 30, 2025 | 0.13 |
| Mar 31, 2025 | 0.14 |
| Dec 31, 2024 | 0.13 |
| Sep 30, 2024 | 0.12 |
| Jun 30, 2024 | 0.12 |
| Mar 31, 2024 | 0.15 |
| Dec 31, 2023 | 0.28 |
| Sep 30, 2023 | 0.41 |
| Jun 30, 2023 | 0.43 |
| Mar 31, 2023 | 0.37 |
| Dec 31, 2022 | 0.33 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | 0.28 |
| Mar 31, 2022 | 0.25 |
| Dec 31, 2021 | 0.21 |
| Sep 30, 2021 | 0.17 |
| Jun 30, 2021 | 0.14 |
| Mar 31, 2021 | 0.09 |
| Dec 31, 2020 | 0.10 |
| Sep 30, 2020 | 0.12 |
| Jun 30, 2020 | 0.08 |
| Mar 31, 2020 | 0.08 |
| Dec 31, 2019 | 0.05 |
| Sep 30, 2019 | 0.03 |
| Jun 30, 2019 | 0.02 |
| Mar 31, 2019 | 0.02 |
| Dec 31, 2018 | 0.03 |
| Sep 30, 2018 | 0.03 |
| Jun 30, 2018 | 0.03 |
| Mar 31, 2018 | 0.03 |
| Dec 31, 2017 | 0.03 |
| Sep 30, 2017 | 0.03 |
| Jun 30, 2017 | 0.02 |
| Mar 31, 2017 | 0.02 |
| Dec 31, 2016 | 0.02 |
| Sep 30, 2016 | 0.02 |
| Jun 30, 2016 | 0.01 |
| Mar 31, 2016 | 0.01 |
| Dec 31, 2015 | 0.01 |
| Sep 30, 2015 | 0.01 |
| Jun 30, 2015 | 0.01 |
| Mar 31, 2015 | 0.01 |
| Dec 31, 2014 | 0.01 |